InvestorsHub Logo
Followers 11
Posts 1915
Boards Moderated 0
Alias Born 04/28/2010

Re: None

Thursday, 03/15/2012 8:08:07 PM

Thursday, March 15, 2012 8:08:07 PM

Post# of 113
I just got one of those propaganda mailers about ORGS today.

It says that ORGS is now Orgenesis

March 13, 2012 09:00 AM Eastern Daylight Time
Orgenesis Inc. Announces Definitive Agreement to Acquire Autologous Insulin Producing Cells (AIPC) Regeneration Technology.

TEL AVIV, Israel--(BUSINESS WIRE)--Orgenesis Inc., (OTCBB: ORGS) (the “Company”) announced today that pursuant to a licensing agreement dated February 2, 2012 with Tel Hashomer - Medical Research, Infrastructure and Services Ltd. ("Tel Hashomer" or "THM), the Company has an exclusive license to develop and commercialize THM's rights in functional autologous insulin producing cells (AIPC) regeneration technology.

“THM), the Company has an exclusive license to develop and commercialize THM's rights in functional autologous insulin producing cells (AIPC) regeneration technology.”


This licensed portfolio is based on the groundbreaking work and two decades of research by the world renowned researcher, Prof. Sarah Ferber conducted at Tel Hashomer.

For the last thirteen years, Prof. Sarah Ferber, Ph.D in Medical Science, the head of the Molecular Endocrinology research unit at the Center for Regenerative Medicine, Stem Cells and Tissue Engineering, Tel Hashomer, has been developing this unique technology, which seeks to substitute malfunctioning organs with new functional tissues created from the patient's own existing organs. This technology employs a molecular and cellular approach directed at converting liver cells into functional insulin producing cells as a treatment for diabetes.


more: http://www.businesswire.com/news/home/20120313005456/en/Orgenesis-Announces-Definitive-Agreement-Acquire-Autologous-Insulin
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ORGS News